References
- BeduneauASaulnierPBenoitJPActive targeting of brain tumors using nanocarriersBiomaterials200728334947496717716726
- PardridgeWMBlood-brain barrier deliveryDrug Discov Today2007121–2546117198973
- WolburgHLippoldtATight junctions of the blood–brain barrier: Development, composition and regulationVascul Pharmacol200238632333712529927
- FauchonFChirasJPoissonMIntra-arterial chemotherapy by cisplatin and cytarabine after temporary disruption of the blood–brain barrier for the treatment of malignant gliomas in adultsJ Neuroradiol19861331511623098932
- KrollRANeuweltEAOutwitting the blood–brain barrier for therapeutic purposes: Osmotic opening and other meansNeurosurgery1998425108310999588554
- LambertDMRationale and applications of lipids as prodrug carriersEur J Pharm Sci200011Suppl 2S15S2711033424
- BodorNBuchwaldPRecent advances in the brain targeting of neuropharmaceuticals by chemical delivery systemsAdv Drug Deliv Rev1999362–322925410837718
- HuwylerJWuDPardridgeWMBrain drug delivery of small molecules using immunoliposomesProc Natl Acad Sci U S A1996932414164141698943078
- BlasiPGiovagnoliSSchoubbenARicciMRossiCSolid lipid nanoparticles for targeted brain drug deliveryAdv Drug Deliv Rev200759645447717570559
- TosiGCostantinoLRuoziBForniFVandelliMAPolymeric nanoparticles for the drug delivery to the central nervous systemExpert Opin Drug Deliv20085215517418248316
- TiwariSBAmijiMMA review of nanocarrier-based CNS delivery systemsCurr Drug Deliv20063221923216611008
- GrefRMinamitakeYPeracchiaMTTrubetskoyVTorchilinVLangerRBiodegradable long-circulating polymeric nanospheresScience19942635153160016038128245
- GulyaevAEGelperinaSESkidanINAntropovASKivmanGYKreuterJSignificant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticlesPharm Res199916101564156910554098
- WilsonBSamantaMKSanthiKKumarKPParamakrishnanNSureshBTargeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticlesEur J Pharm Biopharm2008701758418472255
- HuangCYChenCMLeeYDSynthesis of high loading and encapsulation efficient paclitaxel-loaded poly(n-butyl cyanoacrylate) nanoparticles via miniemulsionInt J Pharm20073381–226727517368981
- AlyautdinRNPetrovVELangerKBertholdAKharkevichDAKreuterJDelivery of loperamide across the blood–brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticlesPharm Res19971433253289098875
- KreuterJAlyautdinRNKharkevichDAIvanovAAPassage of peptides through the blood–brain barrier with colloidal polymer particles (nanoparticles)Brain Res199567411711747773690
- FrieseASeillerEQuackGLorenzBKreuterJIncrease of the duration of the anticonvulsive activity of a novel NMDA receptor antagonist using poly(butylcyanoacrylate) nanoparticles as a parenteral controlled release systemEur J Pharm Biopharm200049210310910704892
- Page-ClissonMEPinto-AlphandaryHOurevitchMAndremontACouvreurPDevelopment of ciprofloxacin-loaded nanoparticles: Physicochemical study of the drug carrierJ Control Release1998561–323329801426
- MiyazakiSTakahashiAKuboWBachynskyJLoebenbergRPoly n-butylcyanoacrylate (PNBCA) nanocapsules as a carrier for NSAIDs: In vitro release and in vivo skin penetrationJ Pharm Pharm Sci20036223824512935436
- MichaelisKHoffmannMMDreisSCovalent linkage of apolipoprotein e to albumin nanoparticles strongly enhances drug transport into the brainJ Pharmacol Exp Ther200631731246125316554356
- KreuterJHekmataraTDreisSVogelTGelperinaSLangerKCovalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brainJ Control Release20071181545817250920
- NewlandsESStevensMFWedgeSRWheelhouseRTBrockCTemozolomide: A review of its discovery, chemical properties, pre-clinical development and clinical trialsCancer Treat Rev199723135619189180
- SampsonJHArcherGEVillavicencioATTreatment of neoplastic meningitis with intrathecal temozolomideClin Cancer Res1999551183118810353755
- TrinhVAPatelSPHwuWJThe safety of temozolomide in the treatment of malignanciesExpert Opin Drug Saf20098449349919435405
- ReydermanLStatkevichPThonoorCMPatrickJBatraVKWirthMDisposition and pharmacokinetics of temozolomide in ratXenobiotica200434548750015370964
- HuangGZhangNBiXDouMSolid lipid nanoparticles of temozolomide: potential reduction of cardial and nephric toxicityInt J Pharm20083551–231432018255242
- WilsonBSamantaMKSanthiKKumarKPParamakrishnanNSureshBPoly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer’s diseaseBrain Res2008120015916818291351
- AmbruosiAYamamotoHKreuterJBody distribution of polysorbate-80 and doxorubicin-loaded [14C]poly(butyl cyanoacrylate) nanoparticles after i.v. administration in ratsJ Drug Target2005131053554216390814
- LobenbergRAraujoLvon BriesenHRodgersEKreuterJBody distribution of azidothymidine bound to hexylcyanoacrylate nanoparticles after i.v. injection to ratsJ Control Release1998501–321309685869
- HeWJiangXZhangZRPreparation and evaluation of polybutylcyanoacrylate nanoparticles for oral delivery of thymopentinJ Pharm Sci20089762250225917853430
- WangCXHuangLSHouLBAntitumor effects of polysorbate-80 coated gemcitabine polybutylcyanoacrylate nanoparticles in vitro and its pharmacodynamics in vivo on C6 glioma cells of a brain tumor modelBrain Res20091261919919401168
- FawazFGuyotMLaguenyAMDevissaguetJPCiprofloxacin-loaded polyisobutylcyanoacrylate nanoparticles: Preparation and characterizationInt J Pharm19971542191203
- BehanNBirkinshawCClarkeNPoly n-butyl cyanoacrylate nanoparticles: A mechanistic study of polymerisation and particle formationBiomaterials200122111335134411336306
- MullerRHJacobsCKayserONanosuspensions as particulate drug formulations in therapy: Rationale for development and what we can expect for the futureAdv Drug Deliv Rev200147131911251242
- GaoKJiangXInfluence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticlesInt J Pharm20063101–221321916426779
- AlyautdinRNTezikovEBRamgePKharkevichDABegleyDJKreuterJSignificant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: An in situ brain perfusion studyJ Microencapsul199815167749463808
- SunWQXieCSWangHFHuYSpecific role of polysorbate 80 coating on the targeting of nanoparticles to the brainBiomaterials200425153065307114967540
- KreuterJNanoparticulate systems for brain delivery of drugsAdv Drug Deliv Rev2001471658111251246